Preoperative risk stratification for endovascular surgery using pharmacologic stress myocardial imaging - 26/08/11
Doi : 10.1016/j.amjcard.2004.08.022
Katsufumi Harafuji, MD a, Taishiro Chikamori, MD a, ⁎ 
, Satoshi Kawaguchi, MD b, Yuko Igarashi, MD a, Hirokazu Tanaka, MD a, Yasuhiro Usui, MD a, Satoshi Hida, MD a, Yoshihiko Yokoi, MD b, Taro Shimazaki, MD b, Shin Ishimaru, MD b, Akira Yamashina, MD a
, Satoshi Kawaguchi, MD b, Yuko Igarashi, MD a, Hirokazu Tanaka, MD a, Yasuhiro Usui, MD a, Satoshi Hida, MD a, Yoshihiko Yokoi, MD b, Taro Shimazaki, MD b, Shin Ishimaru, MD b, Akira Yamashina, MD a a Departments of Department of Internal Medicine II
b Department of Surgery II, Tokyo Medical University, Tokyo, Japan
*Dr. Chikamori's address is: Department of Internal Medicine II, Tokyo Medical University, 6-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo 160-0023, Japan
Résumé |
To stratify perioperative cardiac risk for endovascular surgery, pharmacologic stress single-photon emission computed tomography (SPECT) was performed in 206 patients. Of 8 patients who had cardiac events, 7 occurred in 67 patients with positive SPECT results, whereas only 1 occurred in 139 patients with negative SPECT results (7 of 67 vs 1 of 139, p <0.002). Furthermore, a scintigraphic marker of a summed stress score ≥14 was the most important factor identifying patients who subsequently had cardiac events by multivariate analysis.
Le texte complet de cet article est disponible en PDF.© 2004
Excerpta Medica Inc. Tous droits réservés.
Vol 94 - N° 11
P. 1471-1474 - décembre 2004 Retour au numéro
Article précédent
- Circulating tenascin-C levels in patients with idiopathic dilated cardiomyopathy
- Nobuko Aso, Akira Tamura, Masaru Nasu
- Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure
- Jamshid Alaeddini, Patricia A. Uber, Myung H. Park, Robert L. Scott, Hector O. Ventura, Mandeep R. Mehra
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?